Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir
Alain Pruvost(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Bonaventura Clotet(Universitat de Vic - Universitat Central de Catalunya), Jordi Puig(Universitat Autònoma de Barcelona), Mikaël Levi(Institut de Biologie et Technologies), Rafaela Ayen(Hospital Universitari Germans Trias i Pujol), Frédéric Théodoro(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Jacques Grassi(Universidade Federal do Espírito Santo), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya)
Cited by 73
Related Papers
Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay
|Analytical Chemistry|1985|707
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Screening of 145 Anti-PrP Monoclonal Antibodies for Their Capacity to Inhibit PrPSc Replication in Infected Cells
|Journal of Biological Chemistry|2004|330
Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2.
|Journal of Biological Chemistry|1993|289